Trust Management Rho Net Worth & Insider Trades
Trust Management Rho Vanda Pharmaceuticals Inc
What is Trust Management Rho's Net Worth?
The current estimated net worth of Vanda Pharmaceuticals Inc's Trust Management Rho is estimated to be about $23.7M . Trust Management Rho owns about 1,862,692 units of Vanda Pharmaceuticals Inc common stock. In the last 8 months at Vanda Pharmaceuticals Inc, Trust Management Rho has sold an estimated value of $8.25M worth.
What is Trust Management Rho's Past Insider Trading?
Trust Management Rho's largest sale order was 540,000 units , worth over $8.09M on November 17, 2006. In total, Trust Management Rho has made about 3 transactions over 8 months of their time at Vanda Pharmaceuticals Inc. Trust Management Rho usually trades in November, with the busiest year in 2006.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RHO VENTURES IV LP, RHO VENTURES IV QP LP, KG BETEILIGUNGS CO GMBH VENTURES RHO IV, GMBH VERWALTUNGS PARTNERS CAPITAL RHO, RHO MANAGEMENT VENTURES IV LLC, RHO CAPITAL PARTNERS INC, JOSHUA RUCH, HABIB KAIROUZ, MARK LESCHLY, TRUST MANAGEMENT RHO
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Trust Management Rho's' Mailing Address?
- Mailing address is C/o Rho Capital Partners, Inc. 152 W. 57th Street, 23rd Floor New York NY 10019 NY
Vanda Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Mihael H. Polymeropoulos, M.D. | 2020 | $746,235 | - | $679,200 | $795,830 | $656,687 | $35,468 | $2,913,420 |
| Mihael H. Polymeropoulos, M.D. | 2019 | $721,000 | - | $1,237,200 | $1,610,154 | $675,000 | $34,783 | $4,278,137 |
| Mihael H. Polymeropoulos, M.D. | 2018 | $700,000 | - | $1,131,000 | $1,456,406 | $700,000 | $37,322 | $4,024,728 |
| James P. Kelly | 2020 | $124,057 | - | - | - | - | $16,217 | $140,274 |
| James P. Kelly | 2019 | $493,370 | - | $618,600 | $805,077 | $288,622 | $42,741 | $2,248,410 |
| James P. Kelly | 2018 | $479,000 | - | $754,000 | $832,232 | $299,375 | $36,778 | $2,401,385 |
| Kevin Moran | 2020 | $324,693 | - | $331,101 | $427,779 | $200,000 | $36,126 | $1,319,699 |
| Joakim Wijkstrom | 2020 | $506,422 | - | $339,600 | $397,915 | $250,679 | $29,269 | $1,523,885 |
| Aranthan "AJ" Jones II | 2020 | $406,104 | - | $339,600 | $397,915 | $201,021 | $33,677 | $1,378,317 |
| Timothy Williams | 2020 | $400,000 | - | $339,600 | $397,915 | $200,000 | $41,546 | $1,379,061 |
| Timothy Williams | 2019 | $379,315 | - | $618,600 | $805,077 | $177,520 | $42,342 | $2,022,854 |
| Timothy Williams | 2018 | $144,886 | $40,000 | $643,500 | $1,086,894 | $71,918 | $15,658 | $2,002,856 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1347178/000134717821000008/vnda-20210422xdef14a.htm
What are Vanda Pharmaceuticals Inc's Past Insider Trades?
Vanda Pharmaceuticals Inc's most recent insider trade came on August 23, 2023 by Joakim Wijkstrom who sold 3,724 units worth $21.75K . In the last 17 years, insiders at Vanda Pharmaceuticals Inc have sold an estimated value of $298.14M and bought an estimated value of $28.74M worth of shares. Insider trading is most common in June, with the busiest year in 2006. The most active traders at the company are Mihael Polymeropoulos, President and CEO, James P. Kelly, EVP & Chief Financial Officer, and Richard W Dugan, Director .
Vanda Pharmaceuticals Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||